Vinge has advised Röko AB (publ) (“Röko”) in connection with its listing on Nasdaq Stockholm. The prospectus was published on March 4, 2025 and the first day of trading is March 11, 2025.

The offering price was SEK 2,048 per class B share, corresponding to a total market value for all shares in Röko of approximately SEK 29.95 billion. The total value of the offering amounts to approximately SEK 5,284 million.

Röko is a Sweden-based serial acquirer that has completed 28 platform acquisitions in a variety of industries across Europe. The company's ambition is to be the perpetual owner of small and medium-sized businesses. Historically, Röko has primarily acquired small and medium-sized businesses headquartered in the Nordics and Northern Europe. Röko's organization has more than 100 years of combined experience working with founder- and entrepreneur-led companies in a wide range of industries and the individuals in executive management positions have worked at the company since its first year of operation.

Vinge’s team primarily consisted of Linnéa Sellström, Jesper Schönbeck, Erik Sjöman, Lorin Arabi, Annie Fällström, Michaela Ådén, Karin Karsten, Louise Nässén and Lovisa Jonassen (Capital Markets and Public M&A), Victor EricssonEmelie Svanberg, Erik Kochbati, Marcus Svärd and Ellenor Eckerborn (Corporate Tax), Helena Göransson, Nour Makie and William Carlberg Johansson (Financing), Nicklas Thorgerzon, Martin Boström and Elis Allmark (Commercial agreements, IT and GDPR) Johan Gavelin (Intellectual Property), Gulestan Ali (Regulatory) as well as Louisa Fagarasan (Employment).

Related

Vinge advises Axcel VI and Currentum in connection with the acquisition of Elprojekt Skandinavien

Vinge advises Axcel VI and the Currentum Group in connection with the acquisition of Elprojekt Skandinavien. The company provides complete electrical installations throughout Sweden, focusing on new construction of logistics properties, production facilities, residential buildings and office buildings. Elprojekt Skandinavien had a revenue of SEK 316 million in 2024.
June 23, 2025

Vinge advises Meribel Pharma Solutions

Vinge advises Meribel Pharma Solutions in connection with the sale of a production facility specialising in the manufacture of antibiotics to Apotek Produktion & Laboratorier AB ("APL").
June 23, 2025

Vinge has advised Hansa Biopharma in connection with a directed share issue of approx. SEK 232 million and restructuring of debt financing

Vinge has advised Hansa Biopharma AB (publ) in connection with a directed share issue, through which Hansa raises gross proceeds of approx. SEK 232 million, and restructuring of debt financing. As part of such debt restructuring, Hansa has in conjunction with the directed share issue set-off debt corresponding to approximately USD 14.9 million of its total debt amount.
June 23, 2025